Metabolic Dysfunction-Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel.

ABSTRACT:

Background

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease. Metabolic dysfunction-associated steatohepatitis (MASH), a progressive form of MASLD, can lead to fibrosis and cirrhosis. The incidence and burden of MASH in Germany are expected to double by 2030, while diagnostic and management challenges persist. Expert consensus on diagnostic strategies and treatment modalities in MASLD and MASH is required.

Objectives

The panel aimed to gather insights and consensus on the diagnostic pathway and current treatment modalities for MASH in Germany.

Methods

A three-round web-based survey, integrating Delphi panel methodology with a standard survey, was conducted from February to May 2024 to reach consensus on predefin

SUBMITTER: Kim Y 

PROVIDER: S-EPMC12266315 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature